ACC: Data point to TAVR for high-risk patients

Transcatheter aortic valve replacement may be the better choice for high-risk patients, according to research presented at the American College of Cardiology Scientific Session. High-risk patients who underwent TAVR with Medtronic's CoreValve system experienced lower mortality than those treated with open-heart surgery, according to the study, which "further tilts the balance toward TAVR in high-risk patients," according to SCAI fellow Dr. Ajay Kirtane. A second study that compared the Sapien XT and CoreValve systems generated considerable debate at the meeting.

View Full Article in:

Pittsburgh Post-Gazette · Forbes · Reuters · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN